Intracellular protein homeostasis (or proteostasis) is maintained by stress-responsive signaling pathways such as the heat shock response (HSR).^[@ref1],[@ref2]^ The HSR is an evolutionarily conserved, stress-responsive signaling pathway that adapts the composition of cytosolic proteostasis pathways in response to environmental, genetic, or aging-related stress.^[@ref3],[@ref4]^ The HSR is induced by the accumulation of misfolded proteins within the cytosol, resulting in the activation of stress-responsive transcription factors that induce transcriptional programs including proteostasis network components such as chaperones, cochaperones, folding enzymes, and quality control factors. In mammals, the HSR primarily functions through activation of the winged-helix transcription factor heat shock factor 1 (HSF1).^[@ref3],[@ref4]^ During heat shock, HSF1 activity is regulated through a complex, posttranslational mechanism involving nuclear localization, trimerization, and numerous modifications including phosphorylation and SUMOylation.^[@ref3]−[@ref5]^ Once activated, trimeric HSF1 induces a transcriptional program that remodels the cytosolic proteostasis network in an effort to resolve proteotoxic stress.^[@ref6]−[@ref8]^

HSF1 directly affects cytosolic proteostasis at the level of gene regulation, making HSF1 an attractive therapeutic target to intervene in human diseases etiologically linked to imbalances in cellular proteostasis.^[@ref1],[@ref2],[@ref9]−[@ref12]^ HSF1 overexpression attenuates the pathologic intracellular aggregation of several misfolding-prone proteins, including mutant huntingtin (a protein whose aggregation is pathologically associated with Huntington's disease).^[@ref13]−[@ref16]^ Furthermore, overexpression of HSF1 in mice attenuates symptoms associated with Alzheimer's disease (AD),^[@ref17]^ a neurodegenerative disorder that also involves imbalances in intracellular proteostasis.^[@ref18]−[@ref20]^ The ability of HSF1 overexpression to attenuate pathologic imbalances in intracellular proteostasis associated with these diseases has led to significant effort to identify small-molecule activators of HSF1.^[@ref12],[@ref21]−[@ref23]^ Despite advances in high throughput screening efforts to discover HSF1 activators, further efforts are necessary to hone the response and selectivity of HSF1 activation by small molecules.

In the absence of selective and stress-independent small-molecule HSF1 activators, current approaches have either employed HSF1 overexpression or cell-based assays using heat shock promoter reporter constructs to explore the therapeutic potential for HSF1 activation in ameliorating pathologic imbalances in cytosolic proteostasis.^[@ref24],[@ref25]^ HSF1 overexpression often leads to sustained extremely high levels of HSF1 activity, whereas cell-based assays for the heat shock response may identify compounds that cause proteotoxic damage and mimic cell stress. Consequently, critical questions remain regarding the therapeutic potential for HSF1 activation to treat human disease. Exactly how would sustained stress-independent HSF1 activation similar to what can be achieved using small-molecule HSF1 activators remodel cellular proteostasis pathways? What effects (if any) does stress-independent HSF1-dependent remodeling of cellular proteostasis pathways have on the composition and function of the endogenous cellular proteome not transcriptionally targeted by HSF1? Is there a therapeutic window for HSF1 activation to correct imbalances in cellular proteostasis without resulting in negative physiologic consequences of HSF1 hyperactivation associated with increased tumorigenesis?^[@ref6],[@ref9],[@ref11],[@ref26]^

Here, we evaluate the impact of stress-independent HSF1 activation on cellular proteostasis capacity and global proteome composition. We recently described a ligand-regulated, constitutively active HSF1 fused to a destabilized mutant of FKBP (FKBP·cHSF1) that allows dose-dependent, ligand-mediated induction of HSF1 target genes in the absence of stress.^[@ref27]^ We now show that ligand-dependent FKBP·cHSF1 activation induces the expression of HSF1 target genes to levels nearly identical to those observed during heat shock and significantly less than the levels obtained using more traditional tetracycline (tet)-inducible cHSF1 overexpression. This shows that stress-independent FKBP·cHSF1 activation allows for the increased expression of HSF1 target genes to levels consistent with those that could be obtained using selective HSF1 activators. We employ FKBP·cHSF1 to characterize the remodeling of cellular proteostasis networks induced by stress-independent HSF1 activation using a combined RNAseq transcriptional profiling and whole cell quantitative proteomics approach. Through these efforts, we demonstrate that stress-independent HSF1 activation does not significantly influence the global proteome not transcriptionally targeted by HSF1. Furthermore, we find that the high levels of HSF1 overexpression employed in previous studies are not required to obtain the beneficial consequences of proteostasis network remodeling. Instead, lower levels of HSF1 activation selectively attenuate intracellular aggregation of misfolding-prone proteins and promote cellular survival in response to stress. Collectively, our results provide an essential framework to evaluate stress-independent HSF1 activation as a therapeutic strategy to correct pathologic imbalances in cellular proteostasis associated with human disease.

Results and Discussion {#sec2}
======================

FKBP·cHSF1 Allows Stress-Independent Activation of the HSF1 Transcriptional Program {#sec2.1}
-----------------------------------------------------------------------------------

We established a genetically encoded, small-molecule-regulated fusion between a destabilized mutant of FK506 binding protein 12 and constitutively active HSF1 (FKBP·cHSF1; Figure [1](#fig1){ref-type="fig"}A).^[@ref27]^ When FKBP·cHSF1 is expressed in mammalian cells, the entire fusion protein is rapidly degraded by the proteasome, repressing HSF1 transcriptional activity. This degradation is prevented by the addition of the FKBP·cHSF1 pharmacologic chaperone Shield-1, which stabilizes the entire protein against degradation and allows cHSF1 transcriptional activity.^[@ref27]^

![Shield-1-dependent FKBP·cHSF1 stabilization induces the expression of HSF1 target genes. (A) Illustration showing the posttranslational, Shield-1-mediated regulation of FKBP·cHSF1.^[@ref27]^ (B) Illustration showing doxycycline-mediated induction of cHSF1 expression in cells stably expressing the tetracycline-repressor. (C) Immunoblot of the nuclear fraction from HEK293T-REx cells stably expressing FKBP·cHSF1 or dox-regulated cHSF1. Cells were treated for 15 h with vehicle, Shield-1 (1 μM), or dox (2.25 μM), as indicated. As a control, cells stably expressing FKBP·cHSF1 were heat shocked at 42 °C for 1 h and allowed to recover for 2 h prior to lysis. (D) qPCR of *HSPA1A* in HEK293T-REx cells stably expressing FKBP·cHSF1 or dox-regulated cHSF1. Cells were treated for 15 h with either Shield-1 (1 μM) or dox (2.25 μM), as indicated. HEK293T-Rex cells were also subjected to a 1 h heat shock at 42 °C and a 2 h recovery. Error bars show 95% confidence intervals. (E) qPCR of *DNAJB1* in HEK293T-REx cells stably expressing FKBP·cHSF1 (blue) or dox-regulated cHSF1 (orange). Shield-1 (1 μM) or dox (2.25 μM) was added for the indicated time. The expression of *DNAJB1* was normalized to the maximal expression observed at 24 h. Error bars show 95% confidence interval. (F) qPCR of *DNAJB1* in HEK293T-REx cells stably expressing FKBP·cHSF1 and treated with increasing doses of Shield-1 for 15 h. Error bars show 95% confidence intervals. (G) qPCR of *DNAJB1* in HEK293T-REx cells stably expressing dox-regulated cHSF1 and treated with increasing doses of dox for 15 h. Error bars show 95% confidence intervals. (H) Graph showing the growth of HEK293T-Rex cells stably expressing dox-regulated cHSF1. Dox (2.25 μM) was added, as shown, for the indicated time. Error bar shows SEM for *n* = 4. \*\*\**p*-value \< 0.01. (I) Graph showing the growth of HEK293T-Rex cells stably expressing FKBP·cHSF1. Shield-1 (1 μM) was added for the indicated time.](cb-2014-00062n_0001){#fig1}

Here, we further characterize the Shield-1-dependent regulation of FKBP·cHSF1. We employed HEK293T-Rex cells stably expressing FKBP·cHSF1.^[@ref27]^ We previously showed that FKBP·cHSF1 affords tight, ligand-dependent control over the expression of HSF1 target genes with no increased expression of these genes in the absence of activating ligand.^[@ref27]^ An analogous HEK293T-Rex cell line expressing tet-inducible, unconjugated cHSF1 was prepared for comparison. In these cells, cHSF1 overexpression is induced by the addition of doxycycline (dox) (Figure [1](#fig1){ref-type="fig"}B). These cells show tight, dox-dependent regulation of HSF1 target gene expression (Figure S1A, [Supporting Information](#notes-1){ref-type="notes"}). We confirmed ligand-dependent regulation of FKBP·cHSF1 and tet-inducible cHSF1 by immunoblotting, showing nuclear HSF1 accumulation upon addition of the appropriate activating ligand (Figure [1](#fig1){ref-type="fig"}C). Similarly, protein levels of the HSF1 target genes increase following Shield-1-dependent FKBP·cHSF1 stabilization or dox-dependent cHSF1 overexpression (Figure S1B,C, [Supporting Information](#notes-1){ref-type="notes"}). In the absence of activating ligand, the levels of these proteins were identical to controls, further reflecting the tight ligand-dependent control over HSF1 activity in these cells.

qPCR shows ligand-dependent increases in the expression of the HSF1 target gene *HSPA1A*, which encodes heat shock-inducible HSP70 in each of these cell lines (Figure [1](#fig1){ref-type="fig"}D). The extent of *HSPA1A* mRNA induction by Shield-1-dependent FKBP·cHSF1 stabilization is nearly identical to that observed in HEK293T-Rex cells subjected to heat shock (42 °C; 1 h) and significantly less than that observed for dox-dependent cHSF1 overexpression (Figure [1](#fig1){ref-type="fig"}D). Similar results were observed for the alternative HSF1 target gene *DNAJB1*, which encodes a heat shock-inducible HSP40 (DNAJB1) (Figure S1D, [Supporting Information](#notes-1){ref-type="notes"}). Since the increased expression of *HSPA1A* and *DNAJB1* observed during heat shock reflects levels of gene expression obtainable through endogenous HSF1, these results demonstrate that Shield-1-dependent FKBP·cHSF1 allows for the activation of HSF1 to levels consistent with those obtainable using potential selective small-molecule HSF1 activators.

We next compared the rate of ligand-dependent HSF1 transcriptional activation in cells expressing FKBP·cHSF1 or tet-inducible cHSF1. Posttranslational Shield-1-dependent activation of FKBP·cHSF1 results in a rapid increase in *DNAJB1* expression, with significant induction observed in \<3 h (Figure [1](#fig1){ref-type="fig"}E).^[@ref27]^ In contrast, dox-dependent induction of cHSF1 does not significantly increase *DNAJB1* mRNA levels following 3 h, although dox-dependent cHSF1 overexpression ultimately results in higher *DNAJB1* expression (Figure S1E, [Supporting Information](#notes-1){ref-type="notes"}). Similar results were observed for the alternative HSF1 target gene *HSP90AA1* (Figure S1F, [Supporting Information](#notes-1){ref-type="notes"}).

We further evaluated the differing capacities for FKBP·cHSF1 and tet-inducible cHSF1 activation to regulate the HSF1 transcriptional program in cells treated with increasing concentrations of the appropriate activating ligand (Figure [1](#fig1){ref-type="fig"}F,G). As reported previously,^[@ref27]^ Shield-1-dependent stabilization of FKBP·cHSF1 affords dose-dependent induction of HSF1 target genes such as *DNAJB1*. Dox-dependent cHSF1 overexpression is not readily dosable, showing increased *DNAJB1* expression only once a threshold dox concentration is reached.

The poor dosability of dox-dependent HSF1 activation results in levels of HSF1 activity significantly higher than those observed following heat shock. This is important because it does not realistically represent what selective, small-molecule HSF1 activators could achieve, and very high levels of HSF1 activity could be detrimental to cell viability. Indeed, we found that dox-dependent cHSF1 overexpression reduces cellular viability (Figure [1](#fig1){ref-type="fig"}H). This decrease in cell viability is greater than that observed upon acute heat shock where HSF1 activity is regulated through endogenous stress-dependent signaling (Figure S1G, [Supporting Information](#notes-1){ref-type="notes"}). In contrast, Shield-1-dependent FKBP·cHSF1 stabilization results in only a mild growth defect (Figure [1](#fig1){ref-type="fig"}I).

Collectively, these results show that Shield-1-dependent FKBP·cHSF1 stabilization enables the rapid, dosable stress-independent activation of HSF1 transcriptional targets to levels similar to those observed by heat shock. Importantly, these results demonstrate our ability to separate the heat-dependent posttranslational regulation of HSF1 from activation of this transcription factor in the absence of high levels of HSF1 transcriptional activity observed using the nondosable, dox-dependent induction of cHSF1. While HSF1 activity during heat shock involves additional levels of transcriptional regulation mediated through stress-dependent processes (e.g., posttranslational modification, chromatin remodeling, and heterooligomerization with other HSF transcription factors^[@ref3],[@ref4]^), our establishment of FKBP·cHSF1 provides a mechanism to explore alterations in cellular proteostasis that could be induced by stress-independent activation of HSF1 to levels achievable using small-molecule HSF1 activators.

FKBP·cHSF1 Stabilization Activates the HSF1 Transcriptional Program {#sec2.2}
-------------------------------------------------------------------

We characterized the impact of stress-independent HSF1 transcriptional activation by Shield-1-dependent FKBP·cHSF1 stabilization on gene expression using RNAseq. An analogous experiment was performed to characterize the impact of dox-dependent cHSF1 overexpression as a control. We observed a total of 397 genes whose expression was altered \>2-fold (up- or down-regulated) upon Shield-1-dependent stabilization of FKBP·cHSF1 (FDR \< 0.01; Figure [2](#fig2){ref-type="fig"}A and Table S1, [Supporting Information](#notes-1){ref-type="notes"}). Of these 397 genes, 375 were *increased* while 22 were *decreased*. Alternatively, dox-dependent activation of cHSF1 altered the expression of 1122 genes (fold-change \>2-fold; FDR \< 0.01) (Table S1, [Supporting Information](#notes-1){ref-type="notes"}). Of these 1122 genes, 906 were *increased* while 216 were *decreased*. Genes significantly affected by FKBP·cHSF1 overexpression overlap with those induced by dox-dependent cHSF1 overexpression (96.8% overlap), indicating that the fusion to FKBP does not significantly impact stress-independent HSF1 transcriptional activity (Figure [2](#fig2){ref-type="fig"}A). Genes highly induced by dox-dependent cHSF1 overexpression and Shield-1-dependent FKBP·cHSF1 include many well-known HSF1 target genes induced during heat shock including proteostasis factors such as *HSPA1A*, *HSPA6*, *DNAJB1*, and *BAG3*([@ref6]−[@ref8])(Figure S2A, [Supporting Information](#notes-1){ref-type="notes"}). However, a direct comparison of genes induced by FKBP·cHSF1 versus those induced by heat shock^[@ref7],[@ref28]^ show that stress-independent HSF1 activation and heat shock have distinct but overlapping transcriptional profiles (Figure S2A, [Supporting Information](#notes-1){ref-type="notes"}). These differences likely reflect the additional layers of transcriptional regulation involved in the stress-induced heat shock response including chromatin remodeling, HSF1 posttranslational modification, and the involvement of additional transcription factors.^[@ref3],[@ref4],[@ref29]^ This directly demonstrates the importance of using stress-independent HSF1 activation to evaluate the therapeutic potential of HSF1 to influence cellular proteostasis in the context of human disease, as selective small-molecule HSF1 activators will not activate these other stress-dependent transcriptional regulation pathways. Importantly, we did not observe significant increases in transcriptional markers of other stress-responsive signaling pathways such as the unfolded protein response (e.g., *BiP*,^[@ref30]^ Table [1](#tbl1){ref-type="other"}) or the mitochondrial unfolded protein response (e.g., *DNAJA3*,^[@ref31]^ Table [1](#tbl1){ref-type="other"}), showing that stress-independent HSF1 activation does not induce global cellular stress.

![RNAseq transcriptional profiling of stress-independent HSF1 activation. (A) Diagram showing the overlap of genes with \>2-fold change (FDR \< 0.01) in HEK293T-REx cells following dox-dependent cHSF1 overexpression or Shield-1-dependent FKBP·cHSF1 stabilization. (B) Plot showing the correlation between gene expression in HEK293T-REx cells following Shield-1-dependent FKBP·cHSF1 activation or dox-dependent cHSF1 overexpression. Only genes whose expression is significantly affected (FDR \< 0.01) by dox-dependent cHSF1 overexpression are shown.](cb-2014-00062n_0002){#fig2}

###### mRNA and Protein Level Alterations for Select Cellular Proteostasis Factors Induced by Stress-Independent HSF1 Activation[a](#tbl1-fn1){ref-type="table-fn"}

                                                               fold change in RNAseq   fold change in proteomics          
  ------------------------------------------------------------ ----------------------- --------------------------- ------ ------
   Cytosolic Components of ATP-Dependent Chaperoning Pathways                                                             
                             HSPA1A                            6.6                     5.1                         2.3    1.7
                             HSPA1B                            7.5                     5.3                         2.0    1.5
                             HSPA1L                            15.4                    8.4                         2.1    1.7
                             HSPA6                             40.0                    73.3                        2.4    2.6
                             DNAJA1                            3.8                     3.2                         1.8    1.4
                             DNAJB1                            13.0                    15.5                        8.5    5.4
                             HSPH1                             17.9                    12.2                        3.8    2.3
                             HSPA4                             4.4                     2.3                         1.8    1.4
                              BAG3                             19.1                    19.3                        7.3    3.8
                              CCT4                             2.2                     NS                          NS     NS
                            HSP90AA1                           7.2                     5.1                         1.7    1.5
                            CHORDC1                            3.3                     2.3                         1.6    1.3
                             AHSA1                             4.3                     3.1                         1.7    1.3
                   Small Heat Shock Proteins                                                                              
                             HSPB1                             17.6                    21.4                        19.5   7.8
                             HSPB8                             33.5                    34.4                        ND     ND
                             HSPB9                             4.0                     5.3                         1.4    1.3
                             CRYAB                             35.5                    53.1                        ND     ND
                     ER Folding Chaperones                                                                                
                          HSPA5 (BiP)                          NS                      NS                          NS     NS
                             GRP94                             NS                      NS                          NS     NS
                Mitochondrial Folding Chaperones                                                                          
                         HSPD1 (HSP60)                         4.6                     4.6                         1.7    1.5
                         HSPE1 (HSP10)                         4.0                     3.0                         1.3    1.3
                             DNAJA3                            NS                      NS                          NS     NS
                        HSPA9 (mtHSP70)                        1.5                     1.3                         1.10   1.10

NS indicates not significant (FDR \< 0.01 in RNAseq; *p* \< 0.1 in proteomics). ND indicates protein not quantified in our TMT-MuDPIT proteomic analysis.

The large number of genes altered \>2-fold by dox-dependent cHSF1 overexpression relative to FKBP·cHSF1 activation likely results from the high levels of cHSF1 activation elicited by the tet-inducible system. Consistent with this notion, a plot of the ligand-dependent expression of genes significantly (FDR \< 0.01) altered by dox-dependent cHSF1 overexpression versus the expression of the same genes following Shield-1-dependent FKBP·cHSF1 stabilization (Figure [2](#fig2){ref-type="fig"}B) revealed a linear correlation (*R*^2^ = 0.78). The slope of this line was 0.64 ± 0.01, reflecting the higher levels of HSF1 activation induced by dox-dependent cHSF1 overexpression. Similar results were observed by qPCR where FKBP·cHSF1-dependent induction of HSF1 target genes including *DNAJB1*, *BAG3*, and *GRPEL1* were induced ∼0.64-fold relative to dox-dependent cHSF1 overexpression (see Figures S1D and S2B, [Supporting Information](#notes-1){ref-type="notes"}). These results further show that the FKBP·cHSF1 fusion does not influence HSF1 transcriptional selectivity but results in a more modest induction of HSF1 target genes. Table [1](#tbl1){ref-type="other"} shows mRNA fold changes for select HSF1 target genes altered by Shield-1-dependent FKBP·cHSF1 stabilization or dox-dependent cHSF1 overexpression.

Stress-Independent HSF1 Activity Increases Cellular Proteostasis Capacity {#sec2.3}
-------------------------------------------------------------------------

Functional clustering of the 397 genes whose expression is significantly altered by stress-independent FKBP·cHSF1 activation shows enrichment for cellular proteostasis pathways (Figure [3](#fig3){ref-type="fig"}A and Table S2, [Supporting Information](#notes-1){ref-type="notes"}). By correlation analysis on the expression of 116 primary cellular proteostasis factors (see Table S3, [Supporting Information](#notes-1){ref-type="notes"}) following activation of FKBP·cHSF1 or cHSF1, we identify a cluster of cytosolic factors whose expression is affected similarly by stress-independent HSF1 activation (Figure [3](#fig3){ref-type="fig"}B,C and Figure S3A, [Supporting Information](#notes-1){ref-type="notes"}). This gene network is highly enriched for small heat shock proteins,^[@ref32]^ components of the cytosolic HSP70 chaperoning pathway,^[@ref33],[@ref34]^ and components of the cytosolic HSP90 chaperoning pathway.^[@ref35],[@ref36]^

![Stress-independent HSF1 activation remodels cytosolic proteostasis pathways. (A) Image showing the functional clustering of GO annotations identified in genes showing a \>2-fold change (FDR \< 0.01) in HEK293T-REx cells following Shield-1-dependent FKBP·cHSF1 stabilization. See Table S2 ([Supporting Information](#notes-1){ref-type="notes"}) for additional GO annotations identified in this analysis. (B) Dendrogram of primary proteostasis factors (see Table S3, [Supporting Information](#notes-1){ref-type="notes"}) whose expression is highly correlated following stress-independent HSF1 activation. The color indicates the fold change in mRNA levels observed for specific highly correlated proteostasis factors following Shield-1-dependent FKBP·cHSF1 stabilization, as indicated by the legend. \* indicates a gene only identified in cHSF1 overexpression RNAseq. (C) Cluster analysis of primary proteostasis factors whose expression is highly correlated following stress-independent HSF1 activation. The color indicates the fold change in mRNA levels observed for specific highly correlated proteostasis factors following Shield-1-dependent FKBP·cHSF1 stabilization, as indicated for B. A full correlation of the proteostasis factors described in Table S3 ([Supporting Information](#notes-1){ref-type="notes"}) is shown in Figure S2A ([Supporting Information](#notes-1){ref-type="notes"}). (D) Bar graph showing the log~2~ fold change mRNA of promiscuous (red) and nonpromiscuous (gray) client binding cytosolic HSP40 cochaperones in HEK293T-REx cells following Shield-1-dependent FKBP·cHSF1 stabilization. \*\*\**p*-value \< 0.005. See Table S3 ([Supporting Information](#notes-1){ref-type="notes"}) for the identity of the specific HSP40s used in this analysis. (E) Graph showing the genes whose expression is highly correlated with *DNAJB1* following HSF1 activation. The color indicates the fold-change in mRNA levels induced by FKBP·cHSF1 stabilization.](cb-2014-00062n_0003){#fig3}

Increases in cytosolic proteostasis capacity induced by stress-independent FKBP·cHSF1 activation are best illustrated by the selective increase in cytosolic HSP40s that bind misfolded, aggregation-prone proteins. HSP40s function as cochaperones in the HSP70 chaperoning pathway through the recruitment of misfolded client proteins to HSP70 for ATP-dependent chaperoning and/or promoting HSP70 ATPase activity.^[@ref34],[@ref33]^ HSP40s can be classified into four categories defined by their binding to substrates: (1) promiscuous client binding, (2) selective client binding, (3) no client binding, and (4) unknown client binding.^[@ref34]^ Stress-independent HSF1 activation selectively induces the expression of promiscuous cytosolic HSP40s (e.g., *DNAJB1* and *DNAJA1*) but not HSP40s that demonstrate selective or no client binding (e.g., *DNAJC10* and *DNAJC11*) (Figure [3](#fig3){ref-type="fig"}D). Since promiscuous HSP40s are the cochaperones most responsible for recruiting misfolded, aggregation-prone proteins to ATP-dependent HSP70 chaperoning,^[@ref34],[@ref37],[@ref38]^ selective remodeling of the HSP40 cochaperone pool will result in the increased flux of misfolded, aggregation-prone clients to HSP70s for ATP-dependent chaperoning to the exclusion of more selective, pathway-specific HSP70 activities.

This expression of promiscuous HSP40s induced by stress-independent HSF1 activation is highly correlated with other proteostasis factors that cooperatively prevent intracellular protein aggregation. We observe strong correlations between the promiscuous client binding HSP40 *DNAJB1* and other components of the cytosolic HSP70 chaperoning pathway including cytosolic HSP70s (e.g., *HSPA1A*, *HSPA1B*, and *HSPA6*) and cytosolic nucleotide exchange factors (e.g., *HSPH1* and *HSPA4L*) (Figure [3](#fig3){ref-type="fig"}E). Furthermore, the increased expression of *DNAJB1* correlates with the increased expression of small heat shock proteins (e.g., *HSPB1* and *HSPB9*), potentially reflecting functional cooperation between small heat shock proteins and the HSP70 chaperoning pathways for attenuating intracellular protein aggregation through stress-independent HSF1 activation.^[@ref19]^ Similar correlations are observed for other promiscuous cytosolic HSP40 cochaperones (Figure S3B,C, [Supporting Information](#notes-1){ref-type="notes"}).

Quantitative Proteomics Reveals Remodeling of Cytosolic Proteostasis Pathways Induced by Stress-Independent HSF1 Activation {#sec2.4}
---------------------------------------------------------------------------------------------------------------------------

We quantified proteome-level remodeling of cytosolic proteostasis pathways induced by stress-independent HSF1 activation using tandem mass tag (TMT)-multidimensional protein identification technology (MuDPIT) quantitative proteomics.^[@ref39]−[@ref41]^ We performed TMT-MuDPIT proteomics in triplicate on whole cellular proteomes isolated from HEK293T-Rex cells in the presence or absence of Shield-1-dependent FKBP·cHSF1 stabilization or dox-dependent cHSF1 overexpression. The conditions used for this TMT-MuDPIT analysis were identical to those employed in our RNAseq analysis (see [Supporting Information](#notes-1){ref-type="notes"} for details). In each TMT-MuDPIT experiment, we quantified intracellular levels of \>2400 mammalian proteins (Table S4, [Supporting Information](#notes-1){ref-type="notes"}). Select TMT-MuDPIT data for proteostasis proteins are reported in Table [1](#tbl1){ref-type="other"}.

Proteostasis factors whose mRNA levels are significantly increased by Shield-1-dependent FKBP·cHSF1 stabilization also have increased protein levels (Figure [4](#fig4){ref-type="fig"}A). Identical results were observed for dox-dependent cHSF1 overexpression (Figure [4](#fig4){ref-type="fig"}B). Despite the qualitative correlation between gene expression and protein levels, our results show that mRNA fold changes are generally greater than those observed at the protein level. This observation confirms the importance of combining transcriptional and proteomic profiling of cHSF1 or FKBP·cHSF1 activation to obtain an accurate picture of HSF1-dependent remodeling of cellular proteostasis pathways.^[@ref30]^

![TMT-MuDPIT shows proteome level remodeling of cytosolic proteostasis pathways induced by stress-independent HSF1 activation. (A) Plot showing the log~2~ fold change in proteomics vs the log~2~ fold change in RNAseq for primary proteostasis factors (see Table S3, [Supporting Information](#notes-1){ref-type="notes"}) in HEK293T-REx cells following Shield-1-dependent FKBP·cHSF1 stabilization. (B) Plot showing the log~2~ fold change in proteomics vs the log~2~ fold change in RNAseq for primary proteostasis factors (see Table S3, [Supporting Information](#notes-1){ref-type="notes"}) in HEK293T-REx cells following dox-dependent cHSF1 overexpression. (C) Plot showing the Shield-1-dependent FKBP·cHSF1 stabilization vs log~2~ fold change protein levels for proteostasis factors following dox-dependent cHSF1 overexpression. The proteins are colored by intracellular localization: cytosolic/nuclear (red), blue (ER), green (mitochondrial), and membrane-associated (orange). (D) Illustration showing the protein-level remodeling of the highly correlated cellular proteostasis network shown in Figure [3](#fig3){ref-type="fig"}C. (E) Graph showing the fold increase in protein levels of cytosolic HSP40 proteins identified in our TMT-MuDPIT analyses. HSP40 proteins are categorized based on their client binding; promiscuous HSP40s are shown in red, and nonpromiscuous HSP40s are shown in gray.](cb-2014-00062n_0004){#fig4}

We observe a strong correlation between alterations in protein levels of cellular proteostasis factors induced by Shield-1-dependent FKBP·cHSF1 stabilization or dox-dependent cHSF1 overexpression (*R*^2^ = 0.95) (Figure [4](#fig4){ref-type="fig"}C). The slope of this correlation is 0.69 ± 0.02, which is nearly identical to that observed for a similar comparison of mRNA increases afforded by FKBP·cHSF1 and cHSF1 activation (Figure [2](#fig2){ref-type="fig"}B), further demonstrating that Shield-1-dependent FKBP·cHSF1 activation does not significantly affect stress-independent, HSF1-mediated proteostasis remodeling but offers more subtle remodeling of proteostasis pathways as compared to dox-dependent cHSF1 overexpression.

Mapping alterations in cytosolic proteostasis factors induced by Shield-1-dependent FKBP·cHSF1 stabilization at the protein level on the gene network identified in our bioinformatics analysis (see Figure [3](#fig3){ref-type="fig"}C) confirm that a central core of cytosolic proteostasis factors are altered by stress-independent HSF1 activation (Figure [4](#fig4){ref-type="fig"}D). In particular, core pathways that attenuate pathologic protein aggregation are remodeled, including small heat shock proteins and components of cytosolic HSP70/HSP90 chaperoning pathways. Furthermore, our proteomic analysis confirms that stress-independent FKBP·cHSF1 activation increases cytosolic HSP40 cochaperones that have promiscuous client binding but not those that have selective or no client binding (Figure [4](#fig4){ref-type="fig"}E). Collectively, these results substantiate the stress-independent, HSF1-mediated remodeling of cytosolic proteostasis pathways observed by transcriptional profiling and provide a framework to identify proteostasis network components and pathways accessible through stress-independent HSF1 activation that can be targeted to alleviate pathologic intracellular accumulation of misfolded proteins involved in human disease.

Stress-Independent HSF1 Activation Does Not Globally Disrupt the Cellular Proteome {#sec2.5}
----------------------------------------------------------------------------------

A potential consequence of cytosolic proteostasis remodeling induced by stress-independent HSF1 activation is nontranscriptional alterations in the stability of cellular proteins. These nontranscriptional alterations in protein stability would be reflected by altered steady-state concentrations of proteins whose expression is not affected by stress-independent HSF1 activation. We plotted the −log *p*-value vs log~2~ fold-change of protein of alterations in intracellular protein levels induced by FKBP·cHSF1 activation to identify such nontranscriptional alterations in protein levels (Figure [5](#fig5){ref-type="fig"}A). This analysis identified 24 proteins whose intracellular levels significantly increased (fold change \>1.4 fold; *p*-value \< 0.1). Alternatively, we observed no proteins whose intracellular levels decreased (fold-change \>1.4; *p*-value \< 0.1). Importantly, these proteins were transcriptionally induced by FKBP·cHSF1 (Figure [5](#fig5){ref-type="fig"}B). Similar results were observed for dox-dependent cHSF1 overexpression (Figure [5](#fig5){ref-type="fig"}C,D). While we cannot rule out alterations in intracellular levels of proteins not identified in our MuDPIT analyses, these results suggest that stress-independent HSF1 activation does not globally remodel the composition of the cellular proteome in HEK293T-Rex cells. These results indicate that stress-independent HSF1 activation may provide a therapeutic approach to selectively reduce intracellular protein aggregation without significantly impacting cellular proteome function.

![HSF1 activation does not globally disrupt the composition of the cellular proteome. (A) Plot of −log *p*-value vs log~2~ fold change (Shield-1/vehicle) for proteins identified in our TMT-MuDPIT analysis of HEK293T-REx cells stably expressing FKBP·cHSF1 ± Shield-1 (1 μM; 15 h). (B) Plot showing log~2~ fold change proteomics (Shield-1/vehicle) vs log~2~ fold change RNAseq (Shield-1/vehicle) for proteins identified in HEK293T-REx cells stably expressing FKBP·cHSF1. Only proteins showing a *p*-value \< 0.1 in the TMT-MuDPIT proteomic analysis are shown. (C) Plot of −log *p*-value vs log~2~ fold change (dox/vehicle) for proteins identified in our TMT-MuDPIT analysis of HEK293T-REx cells stably expressing dox-regulated cHSF1 and treated with or without dox (2.25 μM; 15 h). (D) Plot showing log~2~ fold change proteomics (dox/vehicle) vs log~2~ fold change RNAseq (dox/vehicle) for proteins identified in HEK293T-REx cells stably expressing FKBP·cHSF1. Only proteins showing a *p*-value \< 0.1 in the TMT-MuDPIT proteomic analysis are shown.](cb-2014-00062n_0005){#fig5}

Stress-Independent FKBP·cHSF1 Activation Attenuates the Toxicity Induced by Cellular Stress {#sec2.6}
-------------------------------------------------------------------------------------------

We evaluated the capacity of stress-independent HSF1 transcriptional activity to protect the cytosolic proteostasis environment by monitoring the capacity of FKBP·cHSF1 activation to attenuate cellular toxicity induced by heat stress or the environmental toxin arsenite (As(III)), two cellular insults that induce imbalances in cytosolic proteostasis.^[@ref42]−[@ref44]^ FKBP·cHSF1 activation afforded a small but significant increase in cellular viability when HEK293T-Rex cells are challenged with heat (Figure [6](#fig6){ref-type="fig"}A) or As(III) (Figure [6](#fig6){ref-type="fig"}B), consistent with the capacity of stress-independent HSF1 activation to protect cells against stress.

![Stress-independent FKBP·cHSF1 activation attenuates intracellular aggregation of an aggregation-prone model protein. (A) Plot showing the resazurin fluorescence at 24 h of HEK293T-REx cells overexpressing FKBP·cHSF1 or tet-inducible cHSF1 following heat shock (43 °C for 3 h). Cells were pretreated for 15 h with Shield-1 (1 μM) or dox (2.25 μM), as indicated. Error bar shows SEM for *n* = 6; \*\**p*-value \< 0.002 and \**p*-value \< 0.01. (B) Plot showing resazurin fluorescence for HEK293T-Rex cells overexpressing FKBP·cHSF1. Cells were pretreated with 15 h with vehicle or Shield-1 (1 μM) then subjected to a 10 h treatment with the indicated concentration of As(III). Resazurin fluorescence was measured following a 24 h recovery. Error bar shows SEM for *n* = 6; \**p*-value \< 0.01. (C) Fluorescence image of HEK293T cells cotransfected with plasmids encoding polyQ~0~-tdTomato, poly-Q~67~-tdTomato, FKBP·cHSF1, or FKBP·YFP, as indicated. Shield-1 (1 μM) was added 36 h prior to imaging, as indicated. (D) Immunoblot of soluble and insoluble fractions from HEK293T cells cotransfected with a combination of plasmids encoding polyQ~0~-tdTomato or poly-Q~67~-tdTomato, and FKBP·cHSF1 or FKBP·YFP, as indicated. Shield-1 (1 μM) was added 36 h prior to lysis. (E) Quantification of insoluble polyQ~67~-tdTomato from immunoblots as shown in D. \*\* indicates a *p*-value \< 0.002; *n* = 3.](cb-2014-00062n_0006){#fig6}

We next evaluated the capacity of stress-independent HSF1 activation to attenuate cytosolic aggregation of a model, misfolding-prone protein. Cytosolic protein aggregation is a pathologic hallmark of numerous human diseases.^[@ref45]^ Remodeling of the cytosolic proteostasis environment by stress-dependent HSF1 activation or HSF1 overexpression attenuates pathologic intracellular aggregation of destabilized, misfolding-prone proteins such as polyQ.^[@ref13],[@ref46]^ To explore whether stress-independent FKBP·cHSF1 activation can attenuate pathologic aggregation of destabilized proteins, we transfected FKBP·cHSF1 into HEK293T cells stably expressing a protein fusion between an aggregation-prone polyglutamine sequence consisting of 67 glutamine residues and fluorescent tdTomato (polyQ~67~-tdTomato). polyQ~67~-tdTomato efficiently aggregates in these cells shown by the fluorescent puncta observed by fluorescence microscopy (Figure S4, [Supporting Information](#notes-1){ref-type="notes"}). Cells expressing the nonaggregation-prone polyQ~0~-tdTomato show disperse fluorescence, reflecting the lack of aggregation. FKBP·cHSF1 activation decreases the population of intracellular polyQ~67~-tdTomato puncta, indicating decreased intracellular aggregation (Figure [6](#fig6){ref-type="fig"}C). FKBP·cHSF1 activation also attenuates the accumulation of polyQ~67~-tdTomato into insoluble aggregates (Figure [6](#fig6){ref-type="fig"}D,E). Importantly, these effects cannot be attributed to alterations in intracellular polyQ~67~-tdTomato, as total protein levels were not significantly affected by FKBP·cHSF1 activation (Figure [6](#fig6){ref-type="fig"}D). The addition of Shield-1 did not influence puncta formation or incorporation of polyQ~67~-tdTomato into insoluble aggregates in cells transfected with a control plasmid expressing FKBP·YFP (Figure [6](#fig6){ref-type="fig"}C--E). These results show that stress-independent activation of HSF1 to levels achievable with potential small-molecule HSF1 activators is sufficient to increase cytosolic proteostasis capacity and attenuate pathologic protein aggregation.

Concluding Remarks {#sec3}
==================

The holistic activation of stress-responsive signaling pathways has been demonstrated to be more effective in correcting pathological imbalances in proteostasis associated with human disease than the isolated activation of an individual proteostasis network component.^[@ref29]^ The control that HSF1 exhibits over cytosolic proteostasis makes it an attractive therapeutic target to attenuate pathologic imbalances in intracellular proteostasis associated with human disease.^[@ref3],[@ref10],[@ref47]^ The comparisons presented herein between FKBP·cHSF1 and tet-inducible cHSF1 validate FKBP·cHSF1 as a highly regulatable genetic approach to induce the stress-independent HSF1 transcriptional program, providing a critical resource to explore the therapeutic potential for stress-independent HSF1 activation to ameliorate pathologic imbalances in intracellular protein aggregation associated with human disease. We show that stress-independent FKBP·cHSF1 activation alters the composition of the cytosolic proteostasis network to promote cellular viability and prevent intracellular aggregation of misfolding-prone proteins. Additionally, we demonstrate the capacity for stress-independent activation of FKBP·cHSF1 to attenuate intracellular protein aggregation and increase cellular viability in response to proteotoxic insult. Furthermore, transcriptional and proteomic profiling of FKBP·cHSF1 activation provides significant insight into the proteome remodeling afforded by stress-independent HSF1 activation and reveals unique, highly coordinated networks of HSF1-regulated genes that promote cytosolic proteostasis maintenance. Our results validate stress-independent HSF1 activation as a strategy to correct pathologic imbalances in cellular proteostasis associated with human disease, providing significant motivation to identify selective small-molecule HSF1 activators.

Methods {#sec4}
=======

Reagents, Plasmids, and Antibodies {#sec4.1}
----------------------------------

Sodium (meta)arsenite was purchased from Sigma-Aldrich Co. Shield-1 was purchased from Clontech. FKBP·cHSF1·pDEST40, FKBP·YFP·pDEST40, and tet-inducible cHSF1·pTREX-Dest30 were prepared as described previously.^[@ref27]^ To construct ptdtomato-N1-polyQ~67~-tdtomato plasmid, the DNA fragment corresponding to the polyQ coding sequence was amplified by PCR using DNA oligonucleotides, 5′- CCGGAATTCGCCGCCACCATGCACCATCACCACCAGCAACAG-3′ and 5′-GGTGGATCCCCGCCCTCCAGTGGGTGGGGAAA-3′ as primers and pEYFP-N1-82Q as the template.^[@ref48]^ The PCR product was digested with *Eco*RI and *Bam*HI, and cloned into *Eco*RI- and *Bam*HI-digested ptdTomato-N1. The following antibodies were used in this analysis: rabbit polyclonal α-matrin-3 (Bethyl Laboratories), rabbit polyclonal α-HSF1 (Stressgen), and rabbit polyclonal α-RFP.

Cell Culture {#sec4.2}
------------

HEK293T-REx (Invitrogen) cells were cultured in DMEM (CellGro) supplemented with 10% fetal bovine serum (CellGro) and 1% penicillin/streptomycin/glutamine (CellGro). HEK293T-REx cells were cultured in 5 mg/mL blasticidin (InvivoGen) to maintain the tet repressor. HEK293T-REx cells were transiently transfected using calcium phosphate. Stable, clonal HEK293T-REx cell lines were selected from transiently transfected populations using 500 μg/mL G-418 sulfate (Cellgro) for cells expressing pcDNA-DEST40 or pTREx-DEST30 vectors. All stable cell lines were maintained in the appropriate selective antibiotics.

Nuclear Extractions and Western Blot Analyses {#sec4.3}
---------------------------------------------

HEK293T-REx cells were harvested by scraping, and cell pellets were obtained by centrifugation at 1500 rpm. Cells were lysed in 10 mM Hepes (pH 7.5), 50 mM NaCl, 0.5 M sucrose, 0.1 mM EDTA, 0.5% Triton X-100, and complete EDTA-free protease inhibitors (Roche). Nuclear lysates were prepared as previously described.^[@ref30]^ Protein concentrations were normalized by Bradford assays (Bio-Rad). The normalized nuclear lysates were separated by SDS--PAGE and transferred to nitrocellulose membranes. Following blocking and incubation with appropriate primary antibodies, membranes were incubated with 680 and 800 nm fluorophore-labeled secondary antibodies (Li-COR Biosciences) and detected with the Odyssey Infrared Imaging System (Li-COR Biosciences).

Quantitative RT-PCR {#sec4.4}
-------------------

The relative mRNA expression levels of target genes were measured using quantitative RT-PCR. The protocol is detailed in the [Supporting Information](#notes-1){ref-type="notes"}; primers used are listed in Table S3 ([Supporting Information](#notes-1){ref-type="notes"}).

RNA-seq Analyses {#sec4.5}
----------------

FKBP·cHSF1 or cHSF1(dox) cells in 6-well plates were treated for 12 h with vehicle, 1 μM Shield-1 (for FKBP·cHSF1), or 2.25 μM dox (for cHSF1(dox)) in biological triplicate at 37 °C. Cells were harvested, and RNA was extracted using the RNeasy Mini Kit (Qiagen). Genomic DNA was removed by on-column digestion using the RNase-free DNase Set (Qiagen). Detailed protocols for the RNA-seq analyses are provided in the [Supporting Information](#notes-1){ref-type="notes"}.

Tandem Mass Tag Liquid Chromatography--Mass Spectrometry Analyses {#sec4.6}
-----------------------------------------------------------------

FKBP·cHSF1 or cHSF1(dox) cells in 6-well plates were treated for 12 h with vehicle, 1 μM Shield-1 (for FKBP·cHSF1), or 2.25 μM dox (for cHSF1(dox)) in biological triplicate at 37 °C. TMT-labeled peptides were prepared from RIPA-lysed cells according to standard protocols and analyzed by MuDPIT mass spectrometry. Detailed protocols for cell lysis and mass spectrometric analyses are provided in the [Supporting Information](#notes-1){ref-type="notes"}.

Supplemental experimental protocols, complete data tables of RNA-Seq, TMT-MuDPIT, and GO annotation analyses, and supplemental figures supporting the data presented in the main text. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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